About
Pioneers in precision psychiatry
Precision medicine has enabled massive advances in therapeutic areas like oncology and genetic medicine, yet psychiatry continues to follow a trial-and-error approach. Determined to redefine psychiatry, and driven by the belief that patients deserve better, Dr. Amit Etkin founded Alto Neuroscience in 2019 after over a decade of clinical research in his laboratory at Stanford. A former tenured professor, Dr. Etkin is dedicated to creating real-world impact by developing precision treatments for people with neuropsychiatric conditions.
Today, Alto harnesses 15 years of our field-leading neuroscience research and clinical data to match the right patient with the right treatment so that they can get better faster.
Our team
Our work is propelled by a multidisciplinary team of experts with extensive experience in psychiatric drug development, neuroscience, and clinical psychiatry. Together, we’re upending the outdated approach to psychiatric treatment and advancing personalized and data-backed solutions that have already made a meaningful difference for patients.
Management
Advisors
Board of Directors
